InvestorsHub Logo
Followers 0
Posts 1587
Boards Moderated 0
Alias Born 08/09/2015

Re: GD post# 205485

Wednesday, 12/26/2018 12:14:09 PM

Wednesday, December 26, 2018 12:14:09 PM

Post# of 701462
Agreed, if a pharma entity wants to win the China license or the Japan license and wants to get it against less competition they will move early, before the P3 results. I would not be surprised if a China licensing deal is in place prior to results.

And, I also agree that it is quite probable that China has targeted the biotech industry and some entity in China if not the overall govt has targeted DC therapy based on their own DD/work.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News